A comparison of the application of STOPP/START to patients' drug lists with and without clinical information

By Ryan Cristín  

International Journal of Clinical Pharmacy, Vol. 35, Iss. 2, 2013-04 ,pp. : 230-235

Springer Publishing Company

Access to resources Recommend Favorite

Effective Communication of Drug Safety Information to Patients and the Public: A New Look

By Vogt E.M.  

Drug Safety, Vol. 25, Iss. 5, 2002-01 ,pp. : 313-321

Adis International

Access to resources Recommend Favorite

Complementary and Alternative Medicines Use by Cancer Patients and the Role of the Drug Information Pharmacist

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 3, 2012-09 ,pp. : 181-183

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial [Hot Topic:Structuring Chemical Information for Quicker and More Reliable Drug Safety Assessment (Guest Editor: Romualdo Benigni)]

By  

Current Computer - Aided Drug Design, Vol. 2, Iss. 2, 2006-06 ,pp. : 93-94

Bentham Science Publishers

Access to resources Recommend Favorite

The obesity drug market will increase more than six-fold over the next 10 years in the USA, France, Germany, Italy, Spain, Japan and the UK

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 639, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite